Sign In

Friday, January 19, 2018 - 8:00 am to Saturday, January 20, 2018 - 12:30 pm
Add to Calendar

Program Chairs

  • Michael W. Fried, MD, FAASLD
  • Kris V. Kowdley, MD, FACP, FACG, FAASLD

Conference Description

This conference will focus on a variety of topics including novel targets and therapies for NASH, chronic hepatitis B, liver cancer, chronic cholestatic liver disease and portal hypertension. New developments in these therapeutic areas will be addressed from the perspective of the practicing hepatologist and the regulatory professional. Attendees will gain insight on new novel pathways involving nuclear hormone receptors and multidrug combination therapies for chronic hepatitis.  Additionally, the development of biomarkers and the design of treatment studies in HCC and NASH will be covered. 

Location: 
Bethesda North Marriott Rockville, MD